首页> 外文期刊>Journal of Clinical and Diagnostic Research >Dexmedetomidine as an Adjuvant to Ropivacaine in Ultrasound Guided Paediatric Caudal Epidural Block: A Randomised Controlled Study
【24h】

Dexmedetomidine as an Adjuvant to Ropivacaine in Ultrasound Guided Paediatric Caudal Epidural Block: A Randomised Controlled Study

机译:右美托咪定作为罗哌卡因在超声引导的小儿尾硬膜外阻滞中的佐剂:一项随机对照研究

获取原文
           

摘要

Caudal epidural block is a reliable technique to provide perioperative analgesia for infra-umbilical surgeries in paediatric population. Several adjuvants are used along with local anaesthetics to prolong the postoperative anaesthesia.Aim: To evaluate the efficacy of Dexmedetomidine as an adjuvant to ropivacaine in prolonging the duration of postoperative analgesia and reduction of pain scores in paediatric patients undergoing infra-umbilical surgeries.Materials and Methods: This was a double-blinded randomised study, conducted at a tertiary care institution. Sixty patients (2-12 years) of ASA physical status classes 1 and 2 were randomly allocated into two groups. After general anaesthesia, each patient received an ultrasound-guided caudal block. Group R (n=30) received 0.25% ropivacaine (1 mL/kg) +0.5 mL saline and Group RD (n=30) received 0.25% ropivacaine 1 mL/kg +1 μg/kg dexmedetomidine (in 0.5 mL volume). Duration of postoperative analgesia, FLACC pain scores, consumption of rescue analgesics, sedation and adverse-effects were assessed during the 24-hours. The present authors used Student?s t-test and chi-square test for statistical analysis.Results: The duration of postoperative analgesia was significantly prolonged in Group RD, 790.77±7.70 minutes as compared to Group R, 377.97±12.20 minutes (p-value <0.001). Group RD achieved lower FLACC pain scores compared to group R. There were no significant differences in the incidence of adverse-effects.Conclusion: Dexmedetomidine (1 μg/kg) as an adjuvant to ropivacaine 0.25% (1 mL/kg) in an ultrasound-guided caudal block significantly prolongs the duration of postoperative analgesia and reduces FLACC pain score in paediatric patients undergoing infra-umbilical surgeries without any significant adverse-effects.
机译:尾硬膜外阻滞是一种可靠的技术,可为儿科人群的脐下手术提供围手术期镇痛。目的:评估右美托咪定作为罗哌卡因的佐剂在延长术后镇痛持续时间和减少接受脐带下手术的儿科患者的疼痛评分方面的功效。材料与方法:这是在三级护理机构中进行的双盲随机研究。将60例ASA身体状况1级和2级患者(2-12岁)随机分为两组。全身麻醉后,每位患者接受超声引导的尾巴阻滞。 R组(n = 30)接受0.25%罗哌卡因(1 mL / kg)+0.5 mL盐水,RD组(n = 30)接受0.25%罗哌卡因1 mL / kg +1μg/ kg右美托咪定(0.5 mL体积)。在24小时内评估术后镇痛的持续时间,FLACC疼痛评分,急救镇痛剂的消耗量,镇静作用和不良反应。结果:RD组术后镇痛时间显着延长,790.77±7.70分钟,R组为377.97±12.20分钟。 (p值<0.001)。与R组相比,RD组的FLACC疼痛评分更低。不良反应发生率无显着差异。结论:右美托咪定(1μg/ kg)作为罗哌卡因的辅助剂0.25%(1 mL / kg)超声引导下的尾巴阻滞显着延长了术后镇痛的持续时间,并降低了接受脐下手术的小儿患者的FLACC疼痛评分,而没有任何明显的不良影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号